“Cost-Effectiveness Analysis of Peginterferon Beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy: Results of an Updated Analysis”, FE, vol. 19, no. 1, Nov. 2018, doi: 10.7175/fe.v19i1.1385.